Publication
Risk Factors for Mortality in Patients With COVID-19 Needing Extracorporeal Respiratory Support
dc.contributor.author | Riera, J | |
dc.contributor.author | Alcántara, S | |
dc.contributor.author | Bonilla, C | |
dc.contributor.author | Fortuna, P | |
dc.contributor.author | Blandino Ortiz, A | |
dc.contributor.author | Vaz, A | |
dc.contributor.author | Albacete, C | |
dc.contributor.author | Millán, P | |
dc.contributor.author | Ricart, P | |
dc.contributor.author | Boado, MV | |
dc.contributor.author | Ruiz de Gopegui, P | |
dc.contributor.author | Santa Teresa, P | |
dc.contributor.author | Sandoval, E | |
dc.contributor.author | Pérez-Chomón, H | |
dc.contributor.author | González-Pérez, A | |
dc.contributor.author | Duerto, J | |
dc.contributor.author | Gimeno, R | |
dc.contributor.author | Colomina, J | |
dc.contributor.author | Gómez, V | |
dc.contributor.author | Renedo, G | |
dc.contributor.author | Naranjo, J | |
dc.contributor.author | García, MA | |
dc.contributor.author | Rodríguez-Ruiz, E | |
dc.contributor.author | Silva, PE | |
dc.contributor.author | Pérez, D | |
dc.contributor.author | Veganzones, J | |
dc.contributor.author | Voces, R | |
dc.contributor.author | Martínez, S | |
dc.contributor.author | Blanco-Schweizer, P | |
dc.contributor.author | García, M | |
dc.contributor.author | Villanueva-Fernández, H | |
dc.contributor.author | Fuset, MP | |
dc.contributor.author | Luna, S | |
dc.contributor.author | Martínez-Martínez, M | |
dc.contributor.author | Argudo, E | |
dc.contributor.author | Chiscano, L | |
dc.contributor.author | Roncon-Albuquerque, R | |
dc.date.accessioned | 2024-08-07T14:36:32Z | |
dc.date.available | 2024-08-07T14:36:32Z | |
dc.date.issued | 2022-02 | |
dc.description.abstract | When indicating ECMO in patients with COVID-19, centre case volume, age, driving pressure and the duration of symptoms (not the length of MV) should be taken into account. Large drainage cannula and high PEEP levels during the first days are recommended. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Eur Respir J . 2022 Feb 10;59(2):2102463. | pt_PT |
dc.identifier.doi | 10.1183/13993003.02463-2021 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/4973 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Highwire | pt_PT |
dc.subject | HSJ UCI | pt_PT |
dc.subject | COVID-19* | pt_PT |
dc.subject | Humans | pt_PT |
dc.subject | Extracorporeal Membrane Oxygenation* | pt_PT |
dc.subject | Respiratory Distress Syndrome* | pt_PT |
dc.subject | Respiratory Insufficiency* / therapy | pt_PT |
dc.subject | Retrospective Studies | pt_PT |
dc.subject | Risk Factors | pt_PT |
dc.subject | SARS-CoV-2 | pt_PT |
dc.title | Risk Factors for Mortality in Patients With COVID-19 Needing Extracorporeal Respiratory Support | pt_PT |
dc.type | other | |
dspace.entity.type | Publication | |
oaire.citation.issue | 2 | pt_PT |
oaire.citation.startPage | 2102463 | pt_PT |
oaire.citation.title | European Respiratory Journal | pt_PT |
oaire.citation.volume | 59 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | other | pt_PT |